Evidence map›Paper›PMID 30191010›Full record

ArticleHepatic oncology2015

The search for precision models clinically relevant to human liver cancer.

Wen Xue, Xin W Wang

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Hepatic oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wen XueRNA Therapeutics Institute, University of Massachusetts Medical School, 55 N Lake Ave, Worcester, MA 01655, USA.
Xin W WangNational Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USA.

Funding

Investigating microRNA miR-34a in lung cancer development and therapyR00CA169512 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI XUE, WEN · 2014 to 2016
$747k
The role of cancer stem cells in liver cancer heterogeneity and subtypesZ01BC010876 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WANG, XIN · 2008 to 2008
$490k
Intramural NIH HHS Z01 BC010876NCI NIH HHS R00 CA169512
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR technologyhepatocellular carcinomaknockout miceliver cancerRNA interferencetransgenic micetumor heterogeneity

Identifiers

PMID30191010
PMCPMC6095146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.